Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 9 May 2025
First Online: 23 May 2025
Declarations
:
: Not relevant.
: All authors agree on the content of this publication. There is no individual personal data used in this study.
: P.-C.H. is a co-founder of Pilatus Bioscience and serves as an advisor for Elixiron Immunotherapeutics and Celyad Oncology.
